(Total Views: 277)
Posted On: 03/09/2022 3:50:31 PM
Post# of 49
Healthcare Stocks To Watch: $IPA, $HALB, $TBRIF
. Immunoprecise Antibodies Ltd (NASDAQ:IPA) (TSX.V:IPA)
The first of the healthcare stocks that you could start tracking today is that of IPA and for good reason too, considering the fact that the company is in the news this morning owing to a major announcement.
This morning the company provided a report with regards to the latest extent of progress that it has managed to achieve with regards to the development of the PolyTope TATX-03, which is a treatment derived from a cocktail of antibodies. The treatment in question has already been proven to be effective against most of the variants of the COVID 19 virus. This morning IPA announced that it had got positive data from the testing on the product on animals since there were no adverse events that had been recorded.
On the other hand, it was further reported by the company that the product is tolerated well and the margin of safety also proved to be significant. Last but certainly not least, there were no signs of toxicity either. In light of such a positive report, it is likely that the stock is going to come into considerable focus among investors over the course of the coming days. It may be a good time to add it to your watch lists.
https://topnewsguide.com/2022/03/09/healthcar...alb-tbrif/
. Immunoprecise Antibodies Ltd (NASDAQ:IPA) (TSX.V:IPA)
The first of the healthcare stocks that you could start tracking today is that of IPA and for good reason too, considering the fact that the company is in the news this morning owing to a major announcement.
This morning the company provided a report with regards to the latest extent of progress that it has managed to achieve with regards to the development of the PolyTope TATX-03, which is a treatment derived from a cocktail of antibodies. The treatment in question has already been proven to be effective against most of the variants of the COVID 19 virus. This morning IPA announced that it had got positive data from the testing on the product on animals since there were no adverse events that had been recorded.
On the other hand, it was further reported by the company that the product is tolerated well and the margin of safety also proved to be significant. Last but certainly not least, there were no signs of toxicity either. In light of such a positive report, it is likely that the stock is going to come into considerable focus among investors over the course of the coming days. It may be a good time to add it to your watch lists.
https://topnewsguide.com/2022/03/09/healthcar...alb-tbrif/
(0)
(0)Scroll down for more posts ▼
